Cerus (United States)

Recent papers from Cerus (United States)

1. Prospective multi‐centre haemovigilance of amotosalen and ultraviolet A ‐treated platelets and plasma in routine clinical useVox Sanguinis · 2026
2. Engineered Nanobodies To Induce and Visualize Antigen-Specific Tolerance in Rheumatoid Arthritis 2260631The Journal of Immunology · 2026
3. Safety and tolerability of amustaline/glutathione pathogen‐reduced red blood cells in neonatal ratsTransfusion · 2026
4. A low dose is better than no dose: Is it time to consider lowering the US minimum plateletpheresis yield?Transfusion and Apheresis Science · 2026
5. Pathogen‐reduced plasma, cryoprecipitate reduced for therapeutic plasma exchangeTransfusion · 2026
6. Retention of critical platelet hemostatic functions of amotosalen‐ UVA pathogen‐reduced cryoprecipitated fibrinogen complexTransfusion · 2026
7. Amustaline/glutathione pathogen‐reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trialTransfusion · 2025
8. Effects of an amustaline (S‐303)/glutathione pathogen reduction system on the in vitro quality of plasma and platelets in treated whole bloodTransfusion · 2025
9. Transfusion of Amustaline/Glutathione Pathogen-Reduced Red Blood Cells in Cardiac Surgery - A Randomized Phase III Clinical TrialAnesthesiology · 2025
10. Assessing hepatitis B virus infectivity in blood components following pathogen reduction using a human hepatocyte modelTransfusion · 2025
11. A novel acridine flow cytometry marker to track post‐transfusion amustaline/glutathione pathogen‐reduced red blood cell survival in sickle cell disease patientsTransfusion · 2025
12. Human leukocyte antigen alloimmunization in a randomized trial of amustaline/glutathione pathogen‐reduced red cells in complex cardiac surgery patientsTransfusion · 2025
13. Characterizing the antibody response to amustaline/glutathione pathogen‐reduced red blood cellsTransfusion · 2024
14. Trial Of Pathogen-reduced Cryoprecipitate vs. Cryoprecipitated AHF to Lower Operative Transfusions (TOP-CLOT): study protocol for a single center, prospective, cluster randomized trialTrials · 2024
15. Characterization of transfusion‐relevant bacteria reference strains in a lyophilized formatVox Sanguinis · 2024
16. In vivo genotoxicity assessment of N‐(‐9 acridinyl)‐b‐alanine hydrochloride (S‐300) using a validated Pig‐a mutagenesis assayTransfusion · 2024
17. Proliferation of psychrotrophic bacteria in cold‐stored platelet concentratesVox Sanguinis · 2024
18. Spectroscopic view on the interaction between the psoralen derivative amotosalen and DNAPhotochemical & Photobiological Sciences · 2024
19. Acute Pulmonary Injury in Hematology Patients Supported with Pathogen Reduced and Conventional Platelet ComponentsBlood Advances · 2024
20. Analyzing and modeling massive transfusion strategies and the role of fibrinogen—How much is the patient actually receiving?Transfusion · 2024